ARCHIVES

ODAC Recommends Fludarabine Approval for Refractory CLL

This article is from The Cancer Letter archive.

Vol. 16 No. 36 | September 21, 1990

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI CTEP Last Month

September 30, 2011

Case Western Wins Renewal.

October 5, 2001

CCIRC Considers Programs Involved with Including Multimodality Studies

October 10, 1975

MET Inhibitor Improved Time To Progression by 56 Percent

June 29, 2012

In Brief: FDA commissioner Kessler To Resign, Says His Goals Were Accomplished

November 29, 1996

Many Colorectal Cancer Survivors Do Not Receive Recommended Follow-up Care

September 26, 2008